#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prader-Willi syndrome Retinopathy of prematurity Pneumonia Severe myoclonic epilepsy of infancy Cardiac sarcoidosis SAPHO syndrome Hormone-dependent prostate cancer Crohn's disease Small cell lung cancer recurrent B-cell type acute leukaemia Urethral valves Selective polysaccharide antibody deficiency Astrocytoma malignant Ocular lymphoma Medullary thyroid cancer More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Life with Disease Acute respiratory distress syndrome – Treatment Angiosarcoma – Diagnostics Pulmonary sarcoidosis – Trials in Disease Myelodysplastic syndrome with excess blasts – Diagnostics Focal segmental glomerulosclerosis – Life with Disease Primary immunodeficiency syndrome – Diagnostics Myelodysplastic syndrome with excess blasts – Treatment Skin angiosarcoma Leiomyosarcoma recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ABBV-8736 Delandistrogene Moxeparvovec Upadacitinib Izokibep Secale Cereale Roxadustat Flutafuranol (18F) Ruzasvir Dabigatran Etexilate Tildrakizumab Threonine Enoxaparin Sodium Pomalidomide TRIACYLGLYCEROL LIPASE Blu-451 Fosfomycin Platelet Concentrate Povetacicept Digoxin Immune Fab (Ovine) Rezvilutamide More therapies…

    Learn about Your Condition

    Tetanus Oesophageal disorder Abdominal pain IgA nephropathy Klinefelter's syndrome Dupuytren's contracture Left ventricular dysfunction Nocturia Acromegaly Anogenital warts H1N1 influenza Exudative retinopathy Dengue fever Ureteric cancer Myocarditis post infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal transplant

  • Study on the Safety and Effectiveness of Regtivex and Tocilizumab in Patients Receiving HLA-Mismatched Living Donor Kidney Transplants

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Regtivex
    • Tocilizumab
    Austria

  • Personalized Tacrolimus Treatment for Children with Kidney Transplants Using a Dosing Algorithm

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Tacrolimus
    The Netherlands

  • Study on Adjusting Enoxaparin Dose for Children with Kidney Transplants to Prevent Blood Clots

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Enoxaparin Sodium
    France

  • Study on Dulaglutide for Preventing Diabetes in Patients with Metabolic Syndrome Awaiting Kidney Transplantation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Dulaglutide
    Spain

  • Study on Dulaglutide for Preventing Diabetes in New Kidney Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Dulaglutide
    Spain

  • Study on Replacing CNIs with Belatacept for Kidney Transplant Patients with Early Graft Dysfunction 3 to 12 Months Post-Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    France
Previous Page
1 … 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!